Publication of List of Manufacturers Revoked from Licensing for The Manufacture of Therapeutic Goods - Stemtech Pty Ltd

Overview

The Therapeutic Goods Act 1989 was enacted by the Commonwealth Parliament to regulate the provision of therapeutic goods in Australia, addressing gaps in the quality, safety, and efficacy of such goods. This Act was designed to protect public health by ensuring that therapeutic goods available in Australia meet acceptable standards. It provides a framework for the regulation of therapeutic goods through licensing, advertising controls, and other measures to safeguard consumers. The Act's policy objective is to ensure that therapeutic goods are of an acceptable standard and that their benefits outweigh any risks to health. In this context, the revocation of a manufacturer's licence serves to maintain the integrity of the therapeutic goods market by removing substandard or non-compliant entities from the supply chain.

Scope and Application

The Therapeutic Goods Act 1989, administered by the Therapeutic Goods Administration under the Commonwealth of Australia's Department of Health, governs the regulation of therapeutic goods in Australia. This Act applies to both natural and legal persons, encompassing entities such as manufacturers, importers, and suppliers of therapeutic goods. These goods include medicines, medical devices, blood, and tissues, and the Act regulates their manufacture, supply, advertisement, and evaluation to ensure they meet safety, quality, and efficacy standards. The Act's jurisdictional reach is national, covering all therapeutic goods marketed or supplied within Australia, including those imported for local consumption. While the Act broadly applies to all entities involved in the therapeutic goods market, specific exclusions and exemptions may exist, such as for certain research activities or goods used for personal, non-commercial purposes. The application of the Act can be further extended or restricted through subordinate instruments, such as regulations or codes, which provide detailed specifications and operational guidelines for compliance. In the case of Stemtech Pty Ltd, the revocation of its licence to manufacture therapeutic goods under Section 41 of the Act was executed at the request of the licence holder, illustrating the Act's capacity to respond to voluntary compliance measures and maintain the integrity of the therapeutic goods market.

Key Provisions

The main operative sections of the Therapeutic Goods Act 1989, as applied in this case, concern the revocation of a manufacturer's licence. Specifically, Section 41(1)(d) of the Act allows the Secretary to revoke a licence to manufacture therapeutic goods, either on their own initiative or at the request of the licence holder. In this instance, the revocation pertains to Stemtech Pty Ltd, whose licence number is MI-2011-LI-03974-3, and it was carried out at the request of the licence holder themselves (Section 41(1)(d)). The obligations and requirements imposed by the Act on the parties involved primarily centre around maintaining compliance with the standards and regulations set forth by the Therapeutic Goods Administration (TGA). For manufacturers, this includes adhering to good manufacturing practices and ensuring that the therapeutic goods produced are safe, of high quality, and correctly labelled. If a manufacturer fails to meet these standards, the Secretary has the authority to revoke their licence, as seen in this case with Stemtech Pty Ltd. Additionally, the Act requires that any changes in the manufacturing process, location, or other significant operational aspects be reported to and approved by the TGA. In terms of consequences for breaches of the Act, there are both civil and criminal penalties for non-compliance. While the specific maximum penalties for breaches are detailed in other sections of the Act, the revocation of a manufacturer’s licence serves as a significant consequence for failing to meet the regulatory requirements. This action not only halts the manufacturing operations of the entity but also imposes a public record of non-compliance, which can have broader implications for the entity's reputation and future operations. Additionally, continued operation without a valid licence can lead to further legal action, including fines and potential criminal charges.